CAVO, MICHELE
 Distribuzione geografica
Continente #
EU - Europa 240
AS - Asia 1
Totale 241
Nazione #
IT - Italia 239
DE - Germania 1
SG - Singapore 1
Totale 241
Città #
Genoa 122
Genova 55
Rapallo 37
Vado Ligure 25
Frankfurt am Main 1
Singapore 1
Totale 241
Nome #
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study 104
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data 74
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis 36
Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study 20
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma 19
Totale 253
Categoria #
all - tutte 1.250
article - articoli 1.250
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 4 3 4 0 2
2021/202223 2 0 0 1 1 3 0 4 1 7 1 3
2022/202340 2 2 1 3 7 6 0 4 12 2 1 0
2023/202419 2 1 2 4 3 2 1 0 0 0 2 2
2024/202587 1 5 0 2 12 10 11 13 8 6 10 9
2025/202646 30 6 3 7 0 0 0 0 0 0 0 0
Totale 253